Inhaled preparations play an important role in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma. By delivering drugs directly to the lungs, they can reduce systemic side effects and improve efficacy. Pulmonary inhalation has the advantages of little toxic side effects, high bioavailability and no liver first pass effect. This is an important consideration for anyone concerned about lung health. In the enterprise studying the inhalation development of cannabis, we make improvements based on the existing technology in the cannabis vaporizer market and focus on promoting the development in the direction of medical treatment. However, there is still little research and marketization on cannabis medical treatment delivery. How to reduce the impact on the lungs more effectively, and how to effectively provide marijuana users with more healthy and effective ways is a topic that we continue to study;
To give an honest opinion, I found that people who were not able to tolerate smoked cannabis, vaped resins, or vaped distillate with terpenes, were able to tolerate pure, unadulterated distillate with no terpenes added. I thus formed my opinion that with a well cleaned extract lacking in tar, like distillate, terpenes are the main lung irritant and also the main source of allergies and sensitization (compare the famous “hops growers syndrome”.)
No one wants to read chatgpt marketing bs
For some patients with lung diseases, it is recommended not to use marijuana
Terpenes may indeed cause irritation to the respiratory system in some people. Terpenes are a class of organic compounds that are widely found in plants; they also occur naturally in cannabis plants and play a role in adding flavor and possibly affecting effect to cannabis products. However, for some people, terpenes may cause allergic reactions or other adverse reactions, especially when inhaled at high concentrations; Therefore, the development of safer and more tolerable cannabinoid inhalation products is of great significance, NSCAir for different categories of materials in the extensive testing process, we are not only pursuing smoke vaporizers, so that is why we advocate “no smoke,just relief”.
Vapebot AI wants to kill us all.
I wasn’t talking to you, lil bro.
Can we ban users who are clearly bots and/or abusing chatgpt for marketing ploys like folartechvape?
Those products have been tested in markets for the past 5 years but always rejected for one reason or another. I think for someone with a collapsed lung, or any major pulmonary condition- don’t breath in anything other than prescribed by a licensed and trained pulmonologist and clean air. If you don’t like the edible high, look into nano products. Stick with edible, IV, or boof. Life has disqualified you for inhalation of drugs. Sorry bro.
I mean… to be fair, the collapses weren’t caused by smoking; they were caused by pre-existing blebs that have since been removed. I had been smoking for 15 years after the first collapse, and my right lung has been uncompromised the entire time. Since the blebs were removed, it’s practically a normal lung like anyone else’s after recovering from the surgery. If the same lung had collapsed, that’d be a different story. My left lung collapsed spontaneously due to blebs as well, and once again, any unpopped blebs have been removed. Given enough time, I could probably smoke again like anyone else, and the only real risk would be cancer or any other lung disease that everyone is predisposed to. If the unpopped blebs weren’t removed, only then would I be prone to future collapses.
Source: Multiple physical therapists after discussing the risk of smoking post-surgery.
With all that said, I’m still going to quit smoking. I’d be curious to see the failed inhaler products and the reason for their rejections. Personally, I think it’d be expensive to produce and even more costly for the consumer, considering the amount of “puffs” available to a single inhaler and the amount of cannabinoid provided in each unit. The consumer would potentially have to purchase 10+ units a month, depending on their condition.
Also curious about your IV statement. Not sure if I would trust IV cannabinoid on the recreational or even medical market as it currently stands. I don’t think even marinol has an IV form since water solubility comes into question. A cannabinoid solution could certainly have it’s pH adjusted to become soluble in a saline solution, which seems extremely sketchy to me for IV. Either that or some form of THC:DMSO solution in saline, which I also wouldn’t trust.